Immunochemistry Reagents, Analysers And Test Kits: World Market 2013-2023

NEW YORK, April 30, 2013 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

Immunochemistry Reagents, Analysers And Test Kits: World Market 2013-2023
http://www.reportlinker.com/p01169901/Immunochemistry-Reagents-Analysers-And-Test-Kits-World-Market-2013-2023.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=In_Vitro_Diagnostic

Report Details

Immunochemistry - discover technological and commercial prospects

What does the future hold for the immunochemistry market? Visiongain's new report gives you forecasted revenues to 2023. It explains trends, opportunities and prospects for immunochemistry reagents, analysers and test kits. There's rising demand for those products.

Our study lets you assess sales data at overall world market, submarket and national level. There you find that industry's most promising and lucrative segments, helping your research and analyses.

Forecasts and other analyses to help you stay ahead in knowledge

In our work you find revenue forecasting to 2023, historical data, growth rates and market shares. You see qualitative analysis (SWOT analysis), business news, outlooks and developmental trends. You gain 52 tables, 61 charts and a research interview.

Is finding commercial details a challenge? With our report you can get ahead in knowledge, benefiting your research, analyses and decisions. Discover areas that will prosper, reducing the risk of your being left behind.

You discover industry dynamics and growth potentials - the following sections show what you find in our new report.

Discover prospects for the world market and submarkets

Along with revenue prediction for the overall world market, you see forecasts to 2023 for these submarkets:
• Immunochemistry reagents and tests kits
• Immunochemistry analysers

The study also forecasts immunochemistry reagents and tests kits subsectors
• Anaemia/Vitamin tests
• Disease specific tests
• Drugs of abuse/toxicology tests
• Therapeutic drug monitoring
• Endocrinology tests
• Rapid tests

With our investigation you gain business research and analysis with individual sales predictions and discussions. You find analysis of competition, as well as commercial drivers and restraints. See what's likely to achieve the most success.

You can gain competitive advantages by understanding the trends, opportunities and challenges facing the immunochemistry market.

Our work also breaks the main world forecast into leading geographical markets.

What prospects for leading regions and countries?

Developments worldwide will influence the market from 2013, especially the expansion of healthcare in emerging countries. There exist many opportunities for companies developing immunochemistry technologies. See prospects for the industry.

You get individual forecasts to 2023 for nine national markets, finding overall revenues:
• US
• Japan
• Germany, France, UK, Italy and Spain
• India and China.

Discover progress and outlooks. You assess the industry's future - hear about developments and find their significance. Our work explains, exploring many issues.

What issues will affect immunochemistry tests and technologies?

Our report discusses issues and events affecting that industry and market from 2013, looking ahead:
• IVD tests and disease management
• Shift towards decentralisation
• Automation and other technological advancements
• Reimbursement outlook in key segments of the market
• Strengths and weaknesses of the immunochemistry market

Also, you find coverage of these aspects:
• Medical device excise tax
• Regulation of immunochemistry products
• Globalisation of immunochemistry

See what the future holds. You investigate technological, commercial, economic and political matters, with emphasis on the competitive landscape and business outlooks.

Leading companies and 2015 market value

What will happen next? We predict the overall world market for immunochemistry reagents, analysers and test kits will reach $18.1bn in 2015, and expand further to 2023.

Our study shows you what technologies, products and organisations hold greatest potential. We explore these leading companies:
• Roche
• Siemens Healthcare
• Abbott
• Danaher
• Ortho Clinical Diagnostics
• bioMérieux

From 2013 to 2023, many opportunities will arise. Our work shows you the technological and commercial possibilities, helping you stay ahead.

Seven ways Immunochemistry Reagents, Analysers and Test Kits: World Market 2013-2023 helps

To sum up, our investigation gives you the following knowledge:
• Revenues to 2023 for the overall world market and 11 submarkets - you discover that industry's prospects
• Forecasting to 2023 for the US, Japan, Germany, France, UK, Spain, Italy, India and China - you see leading national sales potentials
• Assessments of 6 leading companies - you find activities, products, capabilities and outlooks
• Opinions on the sector - you read our industry interview
• Understanding of competition and opportunities - you see what affects that industry, learning what shapes its future
• Analysis of what stimulates and restrains the industry and market - you assess challenges and strengths
• Prospects for established firms and those seeking to enter the sector - you explore needs, practices and outlooks for success.

Benefit from our analyses, gaining information found nowhere else

That work gives independent analysis from our primary and secondary research. You receive business intelligence found only in our study, seeing where prospects are lucrative and growth is likely.

With our report you are less likely to fall behind in knowledge or miss opportunity. See how our work could benefit your research, analyses and decisions, saving you time and getting you recognition for commercial insight.

Discover technological and commercial prospects from 2013 by ordering now

Visiongain's study is for everyone needing analysis of the industry and market for immunochemistry reagents, analysers and test kits. You find data, trends and predictions. Please ask for our report now.

Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6

Table of Contents

1. Executive Summary
1.1 Sector Highlights
1.2 Aim, Scope and Format of This Report
1.3 Chapter Outline
1.4 Research and Analysis Methods
1.5 Glossary of Terms Relating to the Report

2. Introduction
2.1 What are In Vitro Diagnostic (IVD) Tests?
2.2 Types of IVD Tests
2.2.1 Point of Care Tests
2.2.2 Clinical Chemistry
2.2.3 Haematology
2.2.4 Microbiology
2.2.5 Genetic Testing
2.2.6 Immunochemistry
2.3 The Immune System
2.3.1 What is an Antigen?
2.3.2 What is an Antibody?
2.3.3 Antigen-Antibody Interaction
2.3.4 Affinity and Avidity of Antigen-Antibody Interactions
2.4 Polyclonal and Monoclonal Antibodies
2.5 Regulation of IVD Products
2.5.1 Regulation of IVD in the US
2.5.2 Regulation of IVD in the EU
2.5.3 Regulation of Laboratory Developed Tests

3. Global Immunochemistry Market, 2013-2023
3.1 The Global Medical Device Market, 2011
3.2 Global In Vitro Diagnostics Market, 2011
3.2.1 IVD Market Sectors, 2011
3.2.2 Global IVD Market Trends, 2011
3.3 Global Immunochemistry Market: Segment Analysis, 2011
3.3.1 Global Immunochemistry Market Forecast, 2011-2023
3.3.2 Global Immunochemistry Market Trends, 2013-2023
3.3.2.1 High Demand Due to Increase in Chronic Disease Patient Population
3.3.2.2 Automation of Laboratory Systems
3.3.2.3 Shift Towards Decentralisation
3.3.2.4 Industry Consolidation
3.3.2.5 Investment by Private Equity/ Venture Capital
3.3.2.6 Increased Awareness Through Globalisation
3.3.3 Immunochemistry Market: Drivers and Restraints, 2013-2023

4. Global Immunochemistry Reagents and Test Kits Market, 2013-2023
4.1 Introduction to Immunochemistry Reagents and Test Kits
4.2 Global Immunochemistry Reagents and Test Kits Market by Segment, 2011
4.3 Global Immunochemistry Reagents and Test Kits Market Forecast by Segment, 2012-2023
4.4 Disease Specific Tests Market
4.4.1 Disease Specific Tests Market by Segment, 2011
4.4.2 Disease Specific Tests Market Forecast by Segment, 2012-2023
4.4.3 Disease Specific Tests Market: Drivers and Restraints, 2013-2023
4.4.4 Infectious Diseases
4.4.4.1 Prevalence of Infectious Diseases
4.4.4.2 Infectious Disease Tests Market Forecast, 2012-2023
4.4.4.3 Infectious Disease Tests Market Trends, 2013-2023
4.4.5 Autoimmune Diseases
4.4.5.1 Autoimmune Disease Tests Market Forecast, 2012-2023
4.4.5.2 Autoimmune Disease Tests Market Trends, 2013-2023
4.4.6 Cancer and Tumour Markers
4.4.6.1 What are Tumour Markers?
4.4.6.1.1 Common Tumour Markers
4.4.6.2 Tumour Marker Market Forecast, 2012-2023
4.4.6.3 Tumour Marker Tests Market Trends, 2013-2023
4.4.7 Cardiovascular Diseases and Cardiac Markers
4.4.7.1 Prevalence of Cardiovascular Diseases
4.4.7.2 Common Cardiac Markers
4.4.7.3 Cardiac Marker Market Forecast, 2012-2023
4.4.7.4 Cardiac Marker Market Trends, 2013-2023
4.4.8 Allergic Blood Tests
4.4.8.1 Prevalence of Allergy
4.4.8.2 Allergic Blood Tests Market Forecast, 2012-2023
4.4.8.3 Allergic Blood Tests Market Trends, 2013-2023
4.4.8.4 Leading Allergy Testing Auto-Analysers, 2012
4.4.8.5 Allergy Blood Testing dominated by Phadia (Part of Thermo Fisher)
4.5 Rapid Tests
4.5.1 Rapid Tests Market, 2011
4.5.2 Rapid Tests Market Forecast, 2012-2023
4.5.3 Rapid Tests Market Trends, 2013-2023
4.5.4 Rapid Tests Market: Drivers and Restraints, 2013-2023
4.6 Drugs of Abuse
4.6.1 Extent of Illicit Drug Use
4.6.2 Common Drugs of Abuse
4.6.3 Drugs of Abuse/Toxicology Tests Market Forecast, 2012-2023
4.6.4 Drugs of Abuse/Toxicology Tests Market Trends, 2013-2023
4.6.5 Drugs of Abuse Tests Market: Drivers and Restraints, 2013-2023
4.7 Endocrinology Tests Market, 2011
4.7.1 Endocrinology Tests Market Forecast by Segment, 2012-2023
4.7.2 Trends in the Endocrinology Tests Market, 2013-2023
4.7.3 Endocrinology Tests Market: Drivers and Restraints, 2013-2023
4.8 Therapeutic Drug Monitoring
4.8.1 Commonly Monitored Drugs
4.8.1.1 Antiepileptics
4.8.1.2 Antiarrhythmics
4.8.1.3 Antibiotics
4.8.1.4 Immunosuppressants
4.8.1.5 Bronchodilators
4.8.1.6 Antimanics
4.8.2 Therapeutic Drug Monitoring Market, 2011
4.8.3 Immunoassays Preferred Over Chromatographic Methods for TDM
4.8.4 Therapeutic Drug Monitoring Market Forecast, 2012-2023
4.8.5 Therapeutic Drug Monitoring Market Trends, 2013-2023
4.8.6 Therapeutic Drug Monitoring Market: Drivers and Restraints, 2013-2023
4.9 Anaemia/Vitamin Tests Market, 2011
4.9.1 What is Anaemia?
4.9.2 Types of Anaemia
4.9.2.1 Iron Deficiency Anaemia (IDA)
4.9.2.2 Vitamin Deficiency Anaemia
4.9.3 Diagnosis of Vitamin B12 and Folic Acid Deficiency
4.9.4 Vitamin D Deficiency Affects a Large Population Worldwide
4.9.5 Diagnosis of Vitamin D Deficiency
4.9.5.1 Immunoassays for Vitamin D Measurement
4.9.6 Anaemia/Vitamin Tests Market Forecast, 2012-2023
4.9.7 Anaemia/Vitamin Tests Market Trends, 2013-2023
4.9.8 Regulatory Approvals, 2011-2012
4.9.9 Anaemia/Vitamin Tests Market: Drivers and Restraints, 2013-2023

5. Global Immunochemistry Analysers Market, 2013-2023
5.1 Introduction to Immunochemistry Analysers
5.1.1 Radioimmunoassay Analysers
5.1.2 Enzyme Immunoassay Analysers
5.1.3 Immunofluorescence Analysers
5.1.4 Chemiluminescence Analysers
5.2 Immunochemistry Analysers Market, 2011
5.3 Immunochemistry Analysers Market Forecast by Segment, 2012-2023
5.4 Immunochemistry Analysers Market Trends, 2013-2023

6. Leading National Immunochemistry Markets, 2013-2023
6.1 Regional Breakdown of the Global Immunochemistry Market, 2011
6.2 Global Immunochemistry Market: Regional Forecast, 2012-2023
6.3 The US Market
6.3.1 The US Market: Growth Drivers
6.3.1.1 Increasing Prevalence of Chronic Diseases
6.3.1.2 Strong Growth in the Drugs of Abuse Market
6.3.2 The US Market: Growth Restraints
6.3.2.1 Medical Device Excise Tax
6.4 The European Market
6.4.1 Germany and France
6.4.2 The Italian Market
6.4.3 The Spanish Market
6.4.4 The UK Market
6.5 The Japanese Market
6.6 The Chinese Market
6.7 The Indian Market

7. Leading Companies in the Immunochemistry Market
7.1 Roche
7.1.1 Sales and Recent Performance Analysis, 2011
7.1.2 Roche Diagnostics
7.1.3 Investment in Research and Development
7.1.4 Product Launches in the Immunochemistry Market, 2011
7.1.5 Construction of New Diagnostic Production Facility
7.1.6 Roche: Immunochemistry Analysers
7.1.6.1 Cobas 8000 Analyser
7.1.6.2 Cobas 6000 Analyser
7.1.6.3 Cobas 4000 Analyser
7.2 Siemens
7.2.1 Sales and Recent Performance Analysis, 2012
7.2.2 Siemens Healthcare Sector, 2012
7.2.3 Siemens: R&D Expenses, 2012
7.2.4 Siemens: Immunochemistry Analysers
7.2.4.1 Dimension Vista Systems
7.2.4.2 Advia Centaur XP Immunoassay System
7.2.4.3 Advia Centaur CP Immunoassay System
7.2.4.4 Immulite Series
7.2.4.4.1 Immulite 2000 Immunoassay System
7.2.4.4.2 Immulite 1000 Immunoassay System
7.3 Abbott Laboratories (Now Abbott and AbbVie)
7.3.1 Sales and Performance Analysis, 2011
7.3.2 Immunochemistry Sales: 2009-2011
7.3.3 Abbott: Immunochemistry Analysers
7.3.3.1 Abbott Prism
7.3.3.2 Architect ci8200
7.3.3.3 Architect ci16200
7.3.3.4 Architect ci4100
7.4 Danaher
7.4.1 Sales and Performance Analysis, 2011
7.4.2 Life Sciences & Diagnostics
7.4.3 Danaher: Immunochemistry Analysers
7.5 Ortho Clinical Diagnostics (Part of Johnson & Johnson)
7.5.1 Sales and Performance Analysis, 2011
7.5.2 Ortho Clinical Diagnostics: Immunodiagnostic Analysers
7.6 bioMérieux
7.6.1 Sales and Performance Analysis, 2011
7.6.2 Breakdown of Sales by Technology, 2011
7.6.3 bioMérieux: Collaborations, 2011
7.6.3.1 Collaboration with Royal Philips Electronics
7.6.3.2 Collaboration with Hospices Civils De Lyon

8. SWOT Analysis of the Immunochemistry Market, 2013-2023
8.1 Strengths
8.1.1 Patient Demographics
8.1.2 Automation and Other Technological Advancements
8.1.3 IVD Tests are Vital for Disease Management
8.1.4 Mature Market
8.2 Weaknesses
8.2.1 Regulatory Board Approval
8.3.2 Reimbursement Issues
8.3 Opportunities
8.3.1 Globalisation
8.4 Threats
8.4.1 Medical Device Excise Tax
8.4.2 Regulatory Issues - Lack of Clarity Can be Costly

9. Opinions from Our Industry Survey
9.1 Interview with Godwin Liu, Marketing Manager, Shenzhen Mindray Bio-Medical Electronics Co.
9.1.1 Unmet Needs in the IVD Market
9.1.2 Growth in the IVD Sector
9.1.3 Challenges Faced by the IVD Market
9.1.4 Market Expansion for IVD Products

10. Conclusions
10.1 The Immunochemistry Market, 2013-2023
10.2 Rapid Tests Will Remain the Fastest Growing Segment
10.3 Prominent Companies in the Immunochemistry Market, 2011
10.4 The US was the Leading National Market in 2011
10.5 Future Outlook and Concluding Remarks

List of Tables

Table 3.1 Medical Devices Market: Global Revenue ($bn) and Market Shares (%) by Sector, 2011
Table 3.2 Medical Devices Market: Global Revenue ($bn) and Market Shares (%) by Category, 2011
Table 3.3 IVD Market: Revenue ($bn) and Market Shares (%) by Sector, 2011
Table 3.4 Immunochemistry Market: Revenue ($bn) and Market Shares (%) by Segment, 2011
Table 3.5 Global Immunochemistry Market Forecast ($bn, %), 2011-2023
Table 3.6 Key Mergers & Acquisition Deals, 2011-2012
Table 3.7 Immunochemistry Market: Drivers and Restraints, 2013-2023
Table 4.1 Global Immunochemistry Reagents and Test Kits Market: Revenue ($bn) and Market Shares (%) by Segment, 2011
Table 4.2 Global Immunochemistry Reagents and Test Kits Market Forecast ($bn, %) by Segment, 2011-2017
Table 4.3 Global Immunochemistry Reagents and Test Kits Market Forecast ($bn, %) by Segment, 2017-2023
Table 4.4 Disease Specific Tests Market: Revenue ($bn) and Market Shares (%) by Segment, 2011
Table 4.5 Disease Specific Tests Market Forecast ($bn, %) by Segment, 2011-2017
Table 4.6 Disease Specific Tests Market Forecast ($bn, %) by Segment, 2017-2023
Table 4.7 Disease Specific Tests Market: Drivers and Restraints, 2013-2023
Table 4.8 Common Tumour Markers Used in Diagnosis, 2011
Table 4.9 Common Cardiac Markers Used in Diagnosis, 2011
Table 4.10 Leading Allergy Testing Auto Analysers, 2012
Table 4.11 Rapid Tests Market: Drivers and Restraints, 2013-2023
Table 4.12 Common Drugs of Abuse, 2011
Table 4.13 Drugs of Abuse Market: Drivers and Restraints, 2013-2023
Table 4.14 Commonly Monitored Endocrine Hormones
Table 4.15 Endocrinology Tests: Revenue ($m) and Market Shares (%) by Segment, 2011
Table 4.16 Endocrinology Tests Market Forecast ($m, %) by Segment, 2011-2017
Table 4.17 Endocrinology Tests Market Forecast ($m, %) by Segment, 2017-2023
Table 4.18 Endocrinology Tests Market: Drivers and Restraints, 2013-2023
Table 4.19 Therapeutic Drug Monitoring Market: Drivers and Restraints, 2013-2023
Table 4.20 Anaemia/Vitamin Tests Market: Drivers and Restraints, 2013-2023
Table 5.1 Immunochemistry Analysers Market: Revenue ($bn) and Market Shares (%) by Segment, 2011
Table 5.2 Immunochemistry Analysers Market Forecast ($bn, %) by Segment, 2011-2017
Table 5.3 Immunochemistry Analysers Market Forecast ($bn, %) by Segment, 2017-2023
Table 6.1 Leading National Immunochemistry Markets: Revenue ($bn) and Market Shares (%), 2011
Table 6.2 Global Immunochemistry Market Forecast ($bn, %) by Leading National Markets, 2011-2017
Table 6.3 Global Immunochemistry Market Forecast ($bn, %) by Leading National Markets, 2017-2023
Table 6.4 The Leading European Immunochemistry National Markets: Revenue ($bn) and Market Shares (%) 2011
Table 6.5 The European Immunochemistry Market Forecast ($bn, %) by Leading Countries, 2011-2017
Table 6.6 The European Immunochemistry Market Forecast ($bn, %) by Leading Countries, 2017-2023
Table 7.1 Roche: Net sales ($bn) and Net Sales Shares (%) by Sector, 2011
Table 7.2 Roche Diagnostics: Net Sales ($bn) and Net Sales Shares (%) by Sector, 2011
Table 7.3 Roche: Product Launches in the Immunochemistry Market, 2011
Table 7.4 Siemens: Net sales ($bn) and Net Sales Shares (%) by Sector, 2012
Table 7.5 Siemens Healthcare: Net Sales ($bn) by Sector, 2012
Table 7.6 Siemens: R&D Expenses ($bn), 2012 & 2011
Table 7.7 Abbott: Net Sales ($bn) and Net Sales Shares (%) by Sector, 2011
Table 7.8 Abbott: Immunochemistry Net Sales ($bn), 2009-2011
Table 7.9 Danaher: Net Sales ($bn) and Net Sales Shares (%) by Sector, 2011
Table 7.10 Danaher: Immunochemistry Analysers
Table 7.11 Johnson & Johnson Net sales ($bn) and Net Sales Shares (%) by Brand, 2011
Table 7.12 Ortho Clinical Diagnostics: Immunodiagnostic Analysers
Table 7.13 bioMérieux: Net Sales ($bn) and Net Sales Shares (%) by Sector, 2011
Table 7.14 bioMérieux: Net Sales and Net Sales Shares (%) by Technology, 2011
Table 8.1 SWOT Analysis of the Immunochemistry Market, 2013
Table 10.1 Immunochemistry Market Forecast ($bn, %) by Segments, 2011, 2017, 2019 & 2023

List of Figures

Figure 3.1 Medical Devices Market: Global Revenue ($bn) by Sector, 2011
Figure 3.2 Medical Devices Market: Global Market Shares (%) by Sector, 2011
Figure 3.3 Medical Devices Market: Global Market Shares (%) by Category, 2011
Figure 3.4 IVD Market: Revenue ($bn) by Sector, 2011
Figure 3.5 IVD Market: Market Shares (%) by Sector, 2011
Figure 3.6 Immunochemistry Market: Revenue ($bn) by Segment, 2011
Figure 3.7 Immunochemistry Market: Market Shares (%) by Segment, 2011
Figure 3.8 Global Immunochemistry Market Forecast ($bn), 2011-2023
Figure 4.1 Global Immunochemistry Reagents and Test Kits Market: Revenue ($bn) by Segment, 2011
Figure 4.2 Global Immunochemistry Reagents and Test Kits Market: Market Shares (%), 2011
Figure 4.3 Disease Specific Tests Market: Revenue ($bn) by Segment, 2011
Figure 4.4 Disease Specific Tests Market: Market Shares (%) by Segment, 2011
Figure 4.5 Infectious Disease Tests Market Forecast ($bn), 2011-2023
Figure 4.6 Autoimmune Disease Tests Market Forecast ($bn), 2011-2023
Figure 4.7 Tumour Marker Market Forecast ($bn), 2011-2023
Figure 4.8 Cardiac Marker Market Forecast ($bn), 2011-2023
Figure 4.9 Allergic Blood Tests Market Forecast ($bn), 2011-2023
Figure 4.10 Rapid Tests Market Forecast ($bn), 2011-2023
Figure 4.11 Drugs of Abuse/Toxicology Market Forecast ($bn), 2011-2023
Figure 4.12 Endocrinology Tests Market Shares (%) by Segment, 2011
Figure 4.13 Endocrinology Tests Market Forecast ($m) 2011-2023
Figure 4.14 Thyroid and Fertility Tests Market Forecast ($m), 2011-2023
Figure 4.15 Therapeutic Drug Monitoring Market Forecast ($bn), 2011-2023
Figure 4.16 Anaemia/Vitamin Tests Market Forecast ($bn), 2011-2023
Figure 5.1 Immunochemistry Analysers Market: Revenue ($bn) by Segment, 2011
Figure 5.2 Chemiluminescence Analysers Market Forecast ($bn), 2011-2023
Figure 5.3 Immunochemistry Analysers Market Forecast ($bn) by Segment, 2011-2023
Figure 6.1 Immunochemistry Market: Revenue ($bn) in Leading National Markets, 2011
Figure 6.2 Immunochemistry Market: Market Shares (%) in Leading National Markets, 2011
Figure 6.3 US Immunochemistry Market Forecast ($bn), 2011-2023
Figure 6.4 US Survey of Illicit Drug Use Among People Aged 12 or Older: Numbers (Million), One Month in 2011
Figure 6.5 The Leading European Immunochemistry National Markets: Revenue ($bn), 2011
Figure 6.6 The Leading European Immunochemistry National Markets: Market Shares (%), 2011
Figure 6.7 The European Immunochemistry Market Forecast ($bn), 2011-2023
Figure 6.8 Immunochemistry Market Forecast ($bn) in Germany & France, 2011-2023
Figure 6.9 The Italian Immunochemistry Market Forecast ($bn), 2011-2023
Figure 6.10 The Spanish Immunochemistry Market Forecast ($bn), 2011-2023
Figure 6.11 UK Immunochemistry Market Forecast ($bn), 2011-2023
Figure 6.12 Japanese Immunochemistry Market Forecast ($bn), 2011-2023
Figure 6.13 Chinese Immunochemistry Market Forecast ($bn), 2011-2023
Figure 6.14 Indian Immunochemistry Market Forecast ($bn), 2011-2023
Figure 7.1 Roche: Net Sales ($bn) by Sector, 2011
Figure 7.2 Roche: Net Sales Shares (%) by Sector, 2011
Figure 7.3 Roche Diagnostics: Net Sales ($bn) by Sector, 2011
Figure 7.4 Siemens: Net Sales ($bn) by Sector, 2012
Figure 7.5 Siemens: Net Sales Shares (%) by Sector, 2012
Figure 7.6 Siemens: R&D Expenses ($bn), 2012 & 2011
Figure 7.7 Abbott: Net Sales ($bn) by Sector, 2011
Figure 7.8 Abbott: Net Sales Shares (%) by Sector, 2011
Figure 7.9 Abbott: Immunochemistry Net Sales ($bn), 2009-2011
Figure 7.10 Danaher: Net Sales ($bn) by Sector, 2011
Figure 7.11 Danaher: Net Sales Shares (%) by Sector, 2011
Figure 7.12 Johnson & Johnson: Net sales ($bn) by Brand, 2011
Figure 7.13 Johnson & Johnson: Net Sales Shares (%) by Brand, 2011
Figure 7.14 bioMérieux: Net Sales ($bn) by Sector, 2011
Figure 7.15 bioMérieux: Net Sales Shares (%) by Sector, 2011
Figure 7.16 bioMérieux: Net Sales ($bn) by Technology, 2011
Figure 7.17 bioMérieux: Net Sales Shares (%) by Technology, 2011
Figure 8.1 Countries with Highest Share of 60+ Population, 2011
Figure 10.1 Global Immunochemistry Market Forecast ($bn), 2011, 2017, 2019 & 2023
Figure 10.2 Rapid Tests Market Forecast ($bn), 2011, 2017, 2019 & 2023

Companies Listed

Abbott
Abbott Laboratories
AbbVie
AES laboratoire
Affymetrix
Agilent
Alere
American Diabetes Association
Argene
Axis-Shield PLC
Beckman Coulter
bioMérieux
BioReliance
Biotech Fund Flanders
Cardiovascular Care
Centre for Devices and Radiological Health (CDRH)
Centres for Disease Control and Prevention (CDC)
Danaher
Depuy
DiaSorin
eBioscience
Ernst and Young
eScreen
Ethicon Endosurgery
Eucomed
European Diagnostics Manufacturers Association (EDMA)
Food and Drug Administration (FDA) US
Fujirebio Diagnostics
Gifu University
Gimv
Goldman Sachs
Health Protection Agency (HPA)
Hycor-Agilent
Inova Diagnostics
Iris Healthcare
Italian National Health Service
J Mitra & Co
Johnson & Johnson
Lilac Medicare
Lyon Civil Hospitals
MedSciences Capital (MSC)
Merieux Institute
MP Healthcare Venture Management (MPH)
National Health Service (NHS)
Ortho Clinical Diagnostics
Phadia
Pharmaceutical and Medical Devices Agency (PMDA) Japan
Price Waterhouse Coopers (PWC)
Pronota
Qualigen
Roche
Royal Philips Electronics
Shenzhen Mindray Bio-Medical Electronics Co
Siemens
Siemens Healthcare
Sigma- Aldrich
Span Diagnostics
State Food and Drug Administration
Substance Abuse and Mental Health Services Administration (SAMHSA)
Suyog Diagnostics
Sysmex
Thermo Fisher Scientific
Transasia
Tulip Diagnostics
United Nations
United Nations Office on Drugs and Crime (UNODC)
United Nations Population Division (UNDP)
US National Library of Medicine (NLM)
Valeritas
Vision Care
World Health Organization (WHO)

To order this report:
In_Vitro_Diagnostic Industry: Immunochemistry Reagents, Analysers And Test Kits: World Market 2013-2023

__________________________
Contact Clare: [email protected]
US:(339) 368 6001
Intl:+1 339 368 6001

SOURCE Reportlinker